Testing

Joshua Bornhorst, Ph.D., associate director of Mayo Clinic's Clinical Immunoassay Lab, explains how humans can develop an allergy to the alpha-gal molecule, and he describes a new allergen antibody test that can be used to detect it. Dr. Bornhorst also reviews other tests that should be used in conjunction with alpha-gal testing to accurately identify the scope and underlying cause of the allergy.

By Samantha Rossi • November 17, 2020

Dr. Patel, director of Mayo Clinic's Infectious Diseases Research Laboratory, discussed the future of testing for joint and bone infections.

By Tracy Will • November 12, 2020

Due to the Thanksgiving Day holiday (recognized on Thursday, November 26), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and turnaround times are not affected, please plan ahead.

By Alyssa Frank • November 9, 2020

The following list includes updates posted to mayocliniclabs.com during the month of October.

By Michael Hutchison • November 5, 2020

In October 2020, Mayo Clinic Laboratories announced two new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

By Alyssa Frank • November 5, 2020

Min Shi, M.D., Ph.D., a hematologist and co-director of Mayo Clinic's Flow Cytometry Laboratory, explains recent updates to the B-cell lymphoblastic leukemia minimal residual disease flow cytometry assay. This test is used to identify minimal residual disease in patients with a previously confirmed diagnosis of B-cell lymphoblastic leukemia who have completed chemotherapy, immunotherapy or bone marrow transplantation.

By Samantha Rossi • November 3, 2020

Flu season is just now unfolding. But this time, it’s piggy-backed with a pandemic, which threatens to spike with the colder weather as people huddle indoors. Adding to this conundrum is the unsettling fact that, for both COVID-19 and the flu, the symptoms overlap.

By Christoph Bahn • October 21, 2020

William Sukov, M.D., provides an overview of the MDM2 gene amplification assay — a test that looks for amplification of the MDM2 gene region on chromosome 12q. He reviews when this test should be ordered, how it compares to other test options, and how its results can affect patient care.

By Samantha Rossi • October 20, 2020

In September 2020, Mayo Clinic Laboratories announced one new test along with numerous reference value changes, obsolete tests, and algorithm changes.

By Alyssa Frank • October 8, 2020

The following list includes updates posted to mayocliniclabs.com during the month of September:

CPT Code and Test Classification Updates Test IDTest NameUpdatedFDXM91956DexamethasoneCPT Code Information9/25/2020 4:01pmCDGP63687Congenital Disorders of Glycosylation Genetic Panels, Next-Generation Sequencing, VariesCPT Code Information9/21/2020 4:04pmSUAC83635Succinylacetone, Blood SpotCPT Code Information9/16/2020 12:03pmPN2383640Streptococcus pneumoniae IgG Antibodies, [...]
By Michael Hutchison • October 1, 2020

Lynch syndrome (also known as hereditary nonpolyposis colorectal cancer or HNPCC) is an autosomal dominant hereditary cancer syndrome associated with germline mutations in the mismatch repair genes, MLH1, MSH2, MSH6, and PMS2. Deletions within the 3' end of the EPCAM gene, which lead to inactivation of the MSH2 promotor, have also been associated with Lynch syndrome.

By Alyssa Frank • September 18, 2020

In August 2020, Mayo Clinic Laboratories announced five new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

By Alyssa Frank • September 14, 2020

The results are part of a comprehensive study of 16,175 cases performed at Mayo Clinic over an 11-year period.

By Suzanne Ferguson • September 10, 2020